Neurocrine

$92.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.74 (-0.79%) As of 7:59 PM UTC today

Why Robinhood?

You can buy or sell Neurocrine and other stocks, options, and ETFs commission-free!

About NBIX

Neurocrine Biosciences, Inc. Common Stock, also called Neurocrine, is a neuroscience-focused, biopharmaceutical company.

CEO
Kevin Charles Gorman
Employees
845
Headquarters
San Diego, California
Founded
1992
Market Cap
8.95B
Price-Earnings Ratio
22.42
Dividend Yield
—
Average Volume
3.14M
High Today
$93.33
Low Today
$90.42
Open Price
$92.34
Volume
788.85K
52 Week High
$136.27
52 Week Low
$86.02

NBIX Earnings

$0.00
$0.47
$0.95
$1.42
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours

You May Also Like

IMTB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure